Bayesian Optimal Design for Phase II Screening Trials
From MaRDI portal
Publication:3530110
DOI10.1111/J.1541-0420.2007.00951.XzbMath1145.62057OpenAlexW2055669515WikidataQ34788534 ScholiaQ34788534MaRDI QIDQ3530110
Gary L. Rosner, Meichun Ding, Peter Mueller
Publication date: 15 October 2008
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3075947
Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Bayesian inference (62F15) Bayesian problems; characterization of Bayes procedures (62C10) Sequential statistical design (62L05)
Related Items (5)
Optimal design in geostatistics under preferential sampling ⋮ Bayesian designs and the control of frequentist characteristics: A practical solution ⋮ Approximating the operating characteristics of Bayesian uncertainty directed trial designs ⋮ Decision‐theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta‐binomial distribution ⋮ Adaptive Design Optimization: A Mutual Information-Based Approach to Model Discrimination in Cognitive Science
Cites Work
- Simulation-based sequential Bayesian design
- Optimal screening designs with flexible cost and constraint structures
- Optimal Designs for Evaluating a Series of Treatments
- A Bayesian Approach to the Design of Phase II Clinical Trials
- Optimal Sample Size for a Series of Pilot Trials of New Agents
- An Optimal Design for Screening Trials
- Approaches for Optimal Sequential Decision Analysis in Clinical Trials
- Optimal Two-Stage Design for a Series of Pilot Trials of New Agents
- Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes
- Practical Bayesian Guidelines for Phase IIB Clinical Trials
- Bayesian Analysis of Binary and Polychotomous Response Data
- Screening designs for drug development
This page was built for publication: Bayesian Optimal Design for Phase II Screening Trials
